Form 4: Anixa Biosciences Director Arnold M. Baskies Increases Stake with $15,450 Stock Purchase

Anixa Biosciences Director Arnold M. Baskies reports purchasing 5,000 shares of common stock at $3.09 per share on July 26, 2024, increasing his total holdings to 115,000 shares.

Summary

• On July 26, 2024, Arnold M. Baskies, a director of Anixa Biosciences Inc., purchased 5,000 shares of the company's common stock.
• The purchase price was $3.09 per share.
• This transaction increased Baskies' direct ownership to 115,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director or officer, buys or sells shares of their company's stock. It provides transparency into the transactions of those with privileged information about the company.

Stakeholder Impact

• The stock purchase could have a slightly positive impact on shareholder sentiment.

Key Dates